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ABSTRACT
The pyrimidine(6–4)pyrimidone photoproduct, a major
UV lesion formed between adjacent pyrimidine
bases, is transformed to its Dewar valence isomer
upon exposure to UVA/UVB light. We have synthe-
sized a phosphoramidite building block of the
Dewar photoproduct formed at the thymidylyl
(30–50)thymidine site and incorporated it into oligo-
deoxyribonucleotides. The diastereoisomers of the
partially protected dinucleoside monophosphate
bearing the (6–4) photoproduct, which were caused
by the chirality of the phosphorus atom, were
separated by reversed-phase chromatography, and
the (6–4) photoproduct was converted to the Dewar
photoproduct by irradiation of each isomer with
Pyrex-filtered light from a high-pressure mercury
lamp. The Dewar photoproduct was stable under
both acidic and alkaline conditions at room tem-
perature. After characterization of the isomerized
base moiety by NMR spectroscopy, a phosphorami-
dite building block was synthesized in three steps.
Although the ordinary method could be used for the
oligonucleotide synthesis, benzimidazolium triflate
as an alternative activator yielded better results.
The oligonucleotides were used for the analysis of
the reaction and the binding of Xenopus (6–4)
photolyase. Although the affinity of this enzyme
for the Dewar photoproduct-containing duplex was
reportedly similar to that for the (6–4) photoproduct-
containing substrate, the results suggested a differ-
ence in the binding mode.
INTRODUCTION
Ultraviolet (UV) light causes two major types of photole-
sions, namely cis–syn cyclobutane pyrimidine dimers (CPDs)
and pyrimidine(6–4)pyrimidone photoproducts [(6–4) photo-
products, 2], at dipyrimidine sites (1) in DNA. The (6–4)
photoproduct is converted to another product, originally
designated as TpT3, by irradiation at 313 nm (1). A structural
analysis of TpT3 revealed that the 2-pyrimidone ring of the
(6–4) photoproduct was photoisomerized to a Dewar-type
structure (3) (2), as shown in Scheme 1, and since then, the iso-
merized product has been called the Dewar valence isomer or
the Dewar photoproduct. In addition to the isomerization of
the isolated (6–4) photoproduct (3,4), the Dewar photopro-
ducts are formed by the UVB irradiation of the original pyr-
imidine dinucleoside monophosphates (5,6) or DNA (7).
They are reportedly detected in the DNA of mammalian
cells exposed to simulated or natural sunlight (8–10). Rever-
sion of the Dewar valence isomer to the (6–4) photoproduct
by far-UV irradiation was also described previously (1,11).
The conformation of the Dewar photoproduct of
thymidylyl(30–50)thymidine was determined by NMR spec-
troscopy and molecular modeling, and was found to be simi-
lar to that of the (6–4) photoproduct. However, the 30
component of the Dewar photoproduct, i.e. 5-methyl-2-oxo-
1,3-diazabicyclo[2.2.0]hex-5-ene, is not planar, unlike the 30
base of the (6–4) photoproduct (3). This difference affects the
thermodynamic properties of the base pair formation and
the mutation spectra. While duplexes with guanine opposite
the 30 component of the (6–4) photoproduct are thermodyna-
mically more stable than those with adenine, this stabilization
is reduced by the isomerization to the Dewar photoproduct,
although the functional groups are the same in these two
photoproducts (12,13). The (6–4) photoproduct formed at
the TT sequence causes a T!C transition mutation at the
30 pyrimidone with an extremely high frequency in SOS-
induced Escherichia coli cells, but its Dewar valence isomer
shows lower mutation frequency and speciﬁcity (14,15). The
human damaged DNA-binding protein, which recognizes
DNA containing the (6–4) photoproduct (16) and initiates
global genome nucleotide excision repair (17), binds DNA
containing the Dewar valence isomer with high afﬁnity
(18), and it was demonstrated that the Dewar photoproduct
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human cells, probably via the nucleotide excision repair path-
way (19). Another repair enzyme, the (6–4) photolyase (20),
also binds DNA containing the Dewar photoproduct,
although its afﬁnity for this damaged DNA is slightly lower
than that for the (6–4) photoproduct-containing DNA. The
dissociation constants reported for the (6–4) and Dewar
photoproducts are 5.0 · 10
 10 and 1.4 · 10
 9 M, respectively
(21). However, the repair of the Dewar isomer to the original
pyrimidines by the (6–4) photolyase is extremely slow, and
the reported quantum yield is 0.5% of that obtained for the
repair of the (6–4) photoproduct (21).
For biochemical studies, oligonucleotides containing the
Dewar photoproduct have been prepared by two steps. Short
oligonucleotides containing a single TT sequence were ﬁrst
irradiated at 254 nm, and the resultant products containing
the (6–4) photoproduct were puriﬁed by high-performance
liquid chromatography (HPLC). Subsequently, the (6–4)
photoproduct in these oligonucleotides was converted to its
Dewar valence isomer by a second irradiation step at longer
wavelengths (12,14,22). A problem in this method, however,
is that the HPLC separation of the oligonucleotide containing
the Dewar photoproduct from the starting material containing
the (6–4) photoproduct is very difﬁcult, even though the oli-
gonucleotide is short (12,22). Although the Dewar photopro-
duct is photoequilibrated with the (6–4) photoproduct in
irradiated cells, oligonucleotides free from contamination
with the isomerized form are required for in vitro studies,
and the 100% purity is not guaranteed for the samples pre-
pared by the post-synthetic irradiation method. For the CPD
and the (6–4) photoproduct, methods for the chemical synth-
esis of oligonucleotides using the dinucleotide-type phosphor-
amidite building blocks have been developed previously
(23–26), and the photolesion-containing oligonucleotides
synthesized by this method have been used for various bio-
chemical studies including translesion replication (27–30),
which requires extremely pure template oligonucleotides.
Here we describe the extension of this synthetic method to
the Dewar photoproduct, which enables us to obtain the
Dewar photoproduct-containing oligonucleotides without
any contamination with the (6–4) photoproduct, and its appli-
cation to the analysis of a repair enzyme, (6–4) photolyase.
MATERIALS AND METHODS
General methods
All solvents and reagents were obtained from Wako Pure
Chemical Industries, Ltd. (Osaka, Japan). Reagents for the
DNA synthesizer were purchased from Applied Biosystems
Japan (Tokyo, Japan) and Glen Research (Sterling, VA).
TLC analyses were carried out on Merck Silica gel 60
F254 plates, which were visualized by UV illumination at
254 nm. For column chromatography, Wakogel C-200
(Wako Pure Chemical Industries) was used. For reversed-
phase chromatography, Prep C18 55–105 mm 125 s resin
(Waters Corporation, Milford, MA) was used on a Bio-Rad
Econo System. UV and ﬂuorescence spectra were recorded
on a Shimadzu BioSpec-mini spectrophotometer and a
Shimadzu RF-5300PC spectroﬂuorophotometer, respectively.
1H and
31P NMR spectra were measured on Varian INOVA
600 and JEOL GSX270 spectrometers, respectively. Tetra-
methylsilane and trimethyl phosphate were used as internal
standards. Proton signals were assigned by using homonuc-
lear 2D NMR techniques, correlation spectroscopy (COSY)
and rotating frame Overhauser effect spectroscopy
(ROESY). The ROESY spectra were measured with a mixing
time of 800 ms. Mass spectra were obtained on a Hitachi
M-4000H spectrometer. HPLC analyses were carried out on
a Gilson gradient-type analytical system equipped with a
Waters 2996 photodiode array detector, and a Waters
mBondasphere C18 5mm3 0 0s column (3.9 mm ·
150 mm) was used at a ﬂow rate of 1.0 ml/min with a linear
gradient of acetonitrile in 0.1 M triethylammonium acetate
(pH 7.0). Matrix-assisted laser desorption/ionization time-
of-ﬂight (MALDI-TOF) mass spectra of oligonucleotides
were measured in the negative ion mode on an Applied
Biosystems Voyager DE PRO spectrometer, using
3-hydroxypicolinic acid as a matrix.
Conversion of the (6–4) photoproduct (4a, 4b)
to its Dewar valence isomer (5a, 5b)
The dinucleoside monophosphate of the (6–4) photoproduct
(4a, 4b) was puriﬁed on a column of alkylated silica gel
(1.5 cm · 48 cm) with a linear gradient of 10–25% aqueous
acetonitrile for 400 min, after the UV irradiation described
previously (25). The separated compounds (4a, 191 mg,
273 mmol; 4b, 371 mg, 532 mmol) were dissolved in 20%
aqueous acetonitrile (1.2 l), and after nitrogen bubbling for
10 min, each solution was irradiated in a Pyrex immersion
well apparatus ﬁtted with a 450 W high-pressure mercury
lamp (UM-452; Ushio, Tokyo, Japan) in a 5 C water bath
(NCB-2200; EYELA, Tokyo, Japan) for 1 h. The products
(5a and 5b) were puriﬁed separately on the same column
with an acetonitrile gradient of 10–17.5% (5a) or 10–25%
(5b) for 400 min, and the fractions were analyzed by
reversed-phase HPLC with an acetonitrile gradient from
Scheme 1. The (6–4) photoproduct (2) and its Dewar valence isomer (3) formed at the TT site (1).
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withoutUVabsorptioninthelongwavelengthregionwerecol-
lected, and a glassy solid was obtained after evaporation. 5a:
Yield 94 mg (134 mmol, 49%).
1H-NMR (pyridine-d5) d
(p.p.m.) 12.64 (s, 1H, –NH–), 7.02 (dd, J ¼ 1.9, 9.5 Hz, 1H,
Tp H10), 5.62 (m, 2H, pT H10, Tp H6), 5.50 (m, 1H, Tp H30),
5.32(m,1H,pTH30),4.94(s,1H,pTH6),4.60(m,3H,pTH50,
–OCH2CH2CN), 4.44 (m, 1H, pT H500), 4.33 (dd, J ¼ 2.0,
12.2 Hz, 1H, Tp H50), 4.12 (m, 2H, pT H40,T pH 5 00),
4.01 (m, 1H, Tp H40), 3.28 (m, 1H, Tp H20), 3.12 (m, 2H, –
OCH2CH2CN), 2.84–2.56 (m, 5H, –OCOCH2CH2CO–, Tp
H200), 2.38 (s, 3H, pT, –CH3), 2.19 (m, 2H, pT H20,p TH 2 00),
2.07 (s, 3H, –COCH3), 1.84 (s, 3H, Tp, –CH3).
31P-NMR
(pyridine-d5) d –6.39 p.p.m. HRMS (SI) m/z 720.1889
([M+Na]
+; calcd for C28H36N5O14PNa, 720.1891). 5b: Yield
247 mg (339 mmol, 67%).
1H-NMR (pyridine-d5) d (p.p.m.)
12.61 (s, 1H, –NH–), 7.06 (d, J ¼ 9.1 Hz, 1H, Tp H10), 5.72
(s, 1H, Tp H6), 5.70 (t, J ¼ 8.6 Hz, 1H, Tp H30), 5.65 (dd,
J ¼ 5.6, 9.5 Hz, 1H, pT H10), 5.17 (m, 1H, pT H30), 4.96
(s, 1H, pT H6), 4.60 (m, 1H, pT H50), 4.54 (m, 1H, pT H500),
4.44 (m, 2H, –OCH2CH2CN), 4.32 (d, J ¼ 10.7 Hz, 1H,
Tp H50), 4.22 (d, J ¼ 10.9 Hz, 1H, Tp H500), 4.12 (m,
1H, pT H40), 4.03 (d, J ¼ 7.9 Hz, 1H, Tp H40), 3.26 (dd,
J ¼ 8.6, 14.2 Hz, 1H, Tp H20), 3.02 (t, J ¼ 6.1 Hz,
2H, –OCH2CH2CN), 2.77 (m, 2H, –OCOCH2CH2CO–).
2.68–2.58 (m, 3H, –OCOCH2CH2CO–, Tp H200), 2.36
(s, 3H, pT, –CH3), 2.13 (m, 2H, pT H20,p TH 2 00), 2.07 (s,
3H, –COCH3), 1.91 (s, 3H, Tp, –CH3).
31P-NMR (pyridine-
d5) d –3.27 p.p.m. HRMS (SI) m/z 720.1896 ([M+Na]
+;
calcd for C28H36N5O14PNa, 720.1891).
Protection of the 50-OH function (6a and 6b)
The partially protected dinucleoside monophosphate of the
Dewar photoproduct (5a, 171 mg, 245 mmol) was dissolved
in pyridine (3 ml) and was mixed with 4,40-dimethoxytrityl
(DMT) chloride (211 mg, 623 mmol). After stirring at room
temperature for 3 h, methanol (1.0 ml) was added and the
mixture was concentrated. The residue was dissolved in
chloroform (30 ml), washed with water and was chromato-
graphed, after concentration and coevaporation with toluene,
on silica gel with a step gradient of 0–4% methanol in chloro-
form. The fractions containing the tritylated product were
collected, and 6a was obtained as a foam after evaporation.
The other isomer (5b, 218 mg, 313 mmol) was treated
in the same way. 6a: Yield 204 mg (204 mmol, 83%).
1H-NMR (CDCl3) d (p.p.m.) 7.67 (br, 1H, –NH–), 7.43
(d, J ¼ 4.1 Hz, 2H, aromatic), 7.30 (m, 6H, aromatic), 7.24
(t, J ¼ 7.3 Hz, 1H, aromatic), 6.84 (d, J ¼ 4.4 Hz, 4H,
aromatic), 6.45 (dd, J ¼ 2.8, 9.7 Hz, 1H, Tp H10), 5.56
(dd, J ¼ 6.1, 8.5 Hz, 1H, pT H10), 5.08 (m, 1H, pT H30),
5.00 (s, 1H, pT H6), 4.73 (m, 1H, Tp H30), 4.65 (s, 1H, Tp
H6), 4.37 (d, J ¼11.0 Hz, 1H, pT H50), 4.09 (m, 2H, pT
H500, –OCH2CH2CN), 3.95 (m, 1H, pT H40), 3.82 (m, 2H,
Tp H40, –OCH2CH2CN), 3.79 (s, 6H, –OCH3), 3.72 (dd,
J ¼ 2.6, 11.0 Hz, 1H, Tp H50), 3.48 (br, 1H, –OH), 3.24
(dd, J ¼ 2.9, 11.0 Hz, 1H, Tp H500), 2.86 (m, 1H, Tp H20),
2.81–2.71 (m, 2H, –OCOCH2CH2CO–), 2.65–2.49 (m, 3H,
–OCH2CH2CN, –OCOCH2CH2CO–), 2.40–2.28 (m, 3H, Tp
H200,p TH 2 0, –OCH2CH2CN), 2.19 (s, 3H, –COCH3),
2.09 (m, 1H, pT H200), 2.01 (s, 3H, pT –CH3), 1.51 (s, 3H,
Tp –CH3).
31P-NMR (CDCl3) d –6.85 p.p.m. HRMS (SI)
m/z 1022.3202 ([M+Na]
+; calcd for C49H54N5O16PNa,
1022.3197). 6b: Yield 297 mg (297 mmol, 95%).
1H-NMR
(CDCl3) d (p.p.m.) 7.79 (br, 1H, –NH–), 7.47 (d, J ¼ 8.1
Hz, 2H, aromatic), 7.38 (dd, J ¼ 2.0, 8.9 Hz, 4H, aromatic),
7.30 (t, J ¼ 7.8 Hz, 2H, aromatic), 7.20 (t, J ¼ 7.4 Hz, 1H,
aromatic), 6.84 (d, J ¼ 8.8 Hz, 4H, aromatic), 6.43 (dd,
J ¼ 2.6, 9.7 Hz, 1H, Tp H10), 5.53 (dd, J ¼ 4.7, 10.3 Hz,
1H, pT H10), 5.01 (m, 1H, Tp H30), 4.96 (s, 1H, pT H6),
4.83 (m, 2H, Tp H6, pT H30), 4.31 (m, 1H, pT H50), 4.21
(m, 1H, pT H500), 4.04–3.89 (m, 3H, pT H40, –OCH2CH2CN),
3.78 (s, 6H, –OCH3), 3.72 (d, J ¼ 8.3 Hz, 1H, Tp H40),
3.69 (dd, J ¼ 2.4, 11.1 Hz, 1H, Tp H50), 3.64 (br,
1H, –OH), 3.11 (dd, J ¼ 2.6, 11.2 Hz, 1H, Tp H500), 2.75
(m, 3H, Tp H20, –OCOCH2CH2CO–), 2.64–2.49 (m,
4H, –OCH2CH2CN, –OCOCH2CH2CO–), 2.30–2.20 (m, 2H,
Tp H200,p TH 2 0), 2.18 (s, 3H, –COCH3), 1.94 (m, 1H, pT
H200), 1.90 (s, 3H, pT –CH3), 1.62 (s, 3H, Tp –CH3).
31P-NMR (CDCl3) d –3.44 p.p.m. HRMS (SI) m/z 1022.3190
([M+Na]
+;c a l c df o rC 49H54N5O16PNa, 1022.3197).
Removal of the levulinyl group (7a and 7b)
The protected dinucleoside monophosphate of the Dewar
photoproduct(6a,181mg,181mmol)wasdissolvedinpyridine
(2.3 ml), and a solution (2.3 ml) of hydrazine monohydrate
(88 ml, 1.8 mmol) in pyridine-acetic acid (3:2, v/v) was
added. After stirring at room temperature for 5 min, the
mixture was cooled in an ice bath, and acetone (2.0 ml)
was added. The mixture was diluted with chloroform
(30 ml), washed with 2% aqueous NaHCO3 and with
water, dried with Na2SO4 and concentrated. After coeva-
poration with toluene, the residue was chromatographed on
silica gel (4.8 g) with a step gradient of 0–5% methanol in
chloroform and a product (7a) was obtained as a glassy
solid after evaporation. The other isomer (6b, 454 mg,
454 mmol) was treated in the same way. 7a: Yield 151 mg
(167 mmol, 92%).
1H-NMR (DMSO-d6) d (p.p.m.) 10.46 (s,
1H, –NH–), 7.40 (d, J ¼ 7.7 Hz, 2H, aromatic), 7.26
(m, 7H, aromatic), 6.88 (dd, J ¼ 2.6, 9.2 Hz, 4H, aromatic),
6.29 (dd, J ¼ 2.8, 9.8 Hz, 1H, Tp H10), 5.92 (br, 1H,
Tp –OH), 5.41 (m, 2H, pT H10,3 0-OH), 5.21 (s, 1H, pT
H6), 4.46 (m, 1H, Tp H30), 4.25 (s, 1H, Tp H6), 4.18
(m, 1H, pT H50), 4.10 (m, 1H, pT H30), 3.94 (m, 2H, pT
H500,– O C H2CH2CN), 3.81 (m, 1H, Tp H40), 3.74 (m, 7H,
–OCH2CH2CN, –OCH3), 3.65 (m, 1H, pT H40), 2.77 (m,
1H, Tp H20), 2.69 (m, 2H, –OCH2CH2CN), 2.11 (m, 2H, Tp
H200,p TH 2 0), 2.00 (m, 1H, pT H200), 1.88 (s, 3H, pT
–CH3), 1.39 (s, 3H, Tp –CH3).
31P-NMR (DMSO-d6) d
–6.75 p.p.m. HRMS (SI) m/z 924.2824 ([M+Na]
+; calcd for
C44H48N5O14PNa, 924.2829). 7b: Yield 392 mg (435 mmol,
96%).
1H-NMR (DMSO-d6) d (p.p.m.) 10.46 (s, 1H, –NH–),
7.42 (d, J ¼ 8.3 Hz, 2H, aromatic), 7.30 (m, 6H, aromatic),
7.22 (t, J ¼ 7.3 Hz, 1H, aromatic), 6.87 (dd, J ¼ 2.8, 9.2
Hz, 4H, aromatic), 6.25 (dd, J ¼ 2.8, 9.7 Hz, 1H, Tp H10),
6.00 (br, 1H, Tp –OH), 5.40 (m, 2H, pT H10,3 0-OH), 5.21
(s, 1H, pT H6), 4.93 (m, 1H, Tp H30), 4.42 (s, 1H, Tp H6),
4.19 (d, J ¼ 10.8 Hz, 1H, pT H50), 4.00 (m, 4H, pT H30,
pT H500,– O C H2CH2CN), 3.74 (m, 8H, Tp H40,p TH 4 0,
–OCH3), 3.40 (d, J ¼ 10.7 Hz, 1H, Tp H50), 3.06 (dd, J ¼
2.9, 11.3 Hz, 1H, Tp H500), 2.83 (m, 2H, –OCH2CH2CN),
4408 Nucleic Acids Research, 2006, Vol. 34, No. 162.64 (m, 1H, Tp H20), 2.15 (m, 1H, Tp H200), 1.97 (m, 2H, pT
H20,p TH 2 00), 1.84 (s, 3H, pT –CH3), 1.38 (s, 3H, Tp –CH3).
31P-NMR (DMSO-d6) d –3.29 p.p.m. HRMS (SI) m/z
924.2831 ([M+Na]
+;c a l c df o rC 44H48N5O14PNa, 924.2829).
Phosphoramidite building block of the
Dewar photoproduct (8)
An aliquot of 7b (165 mg, 183 mmol) was mixed with tetra-
hydrofuran (1.6 ml) and N, N-diisopropylethylamine (127 ml,
732 mmol) and 2-cyanoethyl N,N-diisopropylchlorophosphor-
amidite (82 ml, 336 mmol) was added. This mixture was stir-
red at room temperature for 30 min and diluted with ethyl
acetate (40 ml). The resulting solution was washed with 2%
aqueous NaHCO3 and with water, dried with Na2SO4,
concentrated to a gum and coevaporated with toluene. The
residue was chromatographed on silica gel (5 g) with a step
gradient of 0–2% methanol in ice-cooled chloroform con-
taining 0.5% pyridine. The appropriate fractions were col-
lected and concentrated. The residue was dissolved in
chloroform (1 ml) and was precipitated in pentane (20 ml),
and the precipitate was washed with pentane. Yield 166 mg
(151 mmol, 83%).
31P-NMR (CDCl3) d (p.p.m.) 147.04,
146.69, –3.29, –3.53. HRMS (SI) m/z 1124.3919 ([M+Na]
+;
calcd for C53H65N7O15P2Na, 1124.3908).
Oligonucleotide synthesis
The phosphoramidite building block of the Dewar photopro-
duct (8) was dissolved in anhydrous acetonitrile at a concen-
tration of 0.13 M and was installed on an Applied Biosystems
3400 DNA synthesizer. Nucleoside phosphoramidites for
ultramild DNA synthesis (Glen Research), as well as the
base-unprotected thymidine phosphoramidite, were also dis-
solved in acetonitrile to make 0.1 M solutions and were
installed on the synthesizer. Oligonucleotides were synthe-
sized on a 0.2 mmol scale, and the reaction time for the cou-
pling of the Dewar photoproduct building block was
prolonged to 20 min. For the synthesis using benzimidazo-
lium triﬂate (BIT) as an activator, a 0.2 M solution was pre-
pared to replace the tetrazole solution, and a polystyrene
support (Universal Support II PS, Glen Research) was used
without changing the synthesis procedure. After chain assem-
bly and removal of the 50-terminal DMT group on the synthe-
sizer, the solid supports containing the oligonucleotides were
treated with 28% aqueous ammonia (2 ml) at room tempera-
ture for 2 h. The resulting ammoniac solutions were concen-
trated to dryness on a rotary evaporator equipped with a
vacuum pump. The residues were dissolved in water (1 ml)
and the oligonucleotides were analyzed and puriﬁed by
HPLC. The column was heated to 50 C and the acetonitrile
gradients were 5–11, 6–12 and 8–13% for 20 min in the
cases of the 12mer, 20mer and 30mer, respectively. After
puriﬁcation, the HPLC analysis of the 12mer was performed
at room temperature using an acetonitrile gradient from 7 to
13% for 20 min.
Analysis of the (6–4) photolyase reaction
Solutions (180 ml) of Xenopus laevis (6–4) photolyase (31)
(2 nmol), in a buffer containing 10 mM Tris–HCl (pH 8.0)
and 2 mM 2-mercaptoethanol, were covered with a Pyrex
lid and were irradiated on ice with an 18 W ﬂuorescent
lamp at a distance of 15 cm for 30 min. A solution (20 ml)
of the 12mer containing the (6–4) or Dewar photoproduct
(0.2 nmol) was added, and the mixtures were irradiated
again for 3 or 24 h. After heating to 80 C for 30 min, the
mixtures were passed through a NAP-5 column (Amersham
Biosciences AB, Uppsala, Sweden), and the eluates were
Scheme 2. Synthesis of the building block of the Dewar photoproduct.
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for the analysis of the puriﬁed 12mer.
Analysis of the binding of (6–4) photolyase
The 20mer containing the Dewar photoproduct (Dw),
d(CCTACGCAAAT-Dw-GGCATCC), was hybridized to a
complementary strand containing 2-aminopurine (Ap),
d(GGATGCC-Ap-AATTTGCGTAGG), by heating a mixture
(40 ml) of the two oligonucleotides (1.2 nmol each) to 80 C for
3minandcoolingittoroomtemperature.Aduplexwithoutthe
photoproduct was prepared in the same way. These duplexes
were dissolved at 0.3 mM in a buffer containing 50 mM
Tris–HCl (pH 8.0), 50 mM NaCl, 1 mM 2-mercaptoethanol
and 10% glycerol, and ﬂuorescence spectra were measured
at 5 C, in the absence or presence of 350 nM X.laevis
(6–4) photolyase. The excitation wavelength was 313 nm.
Experiments using the undamaged and (6–4) photoproduct-
containing duplexes were performed in the same way.
RESULTS AND DISCUSSION
Formation and stability of the Dewar photoproduct
We intended to synthesize oligonucleotides containing the
Dewar photoproduct formed at the TT sequence (3) using a
dinucleotide building block, to extend our previous studies
on the (6–4) photoproduct (25,26). Before the preparation
of the building block, we analyzed the formation and the sta-
bility of the Dewar photoproduct. A solution of the dinucleo-
side monophosphate of the (6–4) photoproduct (2), which
was obtained by deprotection of the intermediate in the pre-
paration of the (6–4) photoproduct building block (a mixture
of compounds 4a and 4b in Scheme 2), was irradiated on ice
in a petri dish with a Pyrex lid using a 100 W high-pressure
mercury lamp covered with a Pyrex water jacket. HPLC ana-
lysis of the irradiated solution on a reversed-phase column is
shown in Figure 1A. A new peak emerged, and the (6–4)
photoproduct was converted to this product almost comple-
tely in 4 h. We assigned this product as the Dewar valence
isomer (3) because the absorption at wavelengths longer
than 260 nm was lost (Figure 1B), as reported for the
Dewar photoproduct (1,32).
The dinucleoside monophosphate of the Dewar photopro-
duct formed in the above experiment was used to analyze
its stability. Compound 3 was treated with acetic acid at
room temperature for 1 h to conﬁrm that the damaged base
would not be degraded during the DMT removal step in
every cycle of oligonucleotide synthesis. Another experiment
was its treatment with aqueous ammonia at room temperature
for 2 h, which is used for the deprotection of oligonucleotides
synthesized by the ‘ultramild’ method. The latter analysis is
very important, because the Dewar isomer is reportedly
more labile than the (6–4) photoproduct under alkaline condi-
tions (11,22). HPLC analysis of the reaction mixtures
revealed that the Dewar photoproduct was stable under
both of these conditions, although a very small peak was
detected at a short retention time after the ammonia treatment
(Supplementary Figure 1).
The phosphoramidite building block of the
Dewar photoproduct
Although the Dewar photoproduct can be obtained directly by
irradiation of thymidylyl(30–50)thymidine at wavelengths
longer than 280 nm, its yield by this method is very low
(2). Therefore, the (6–4) photoproduct prepared by our
previous method (25) was isomerized in this study. After
the formation of the (6–4) photoproduct by irradiation of
the protected thymidylyl(30–50)thymidine with germicidal
lamps, the diastereomers caused by the chirality of the phos-
phorus atom were separated by reversed-phase chromatogra-
phy on alkylated silica gel, as described previously (25). The
isomers with shorter and longer retention times in reversed-
phase HPLC analysis were designated as 4a and 4b, respec-
tively. Each diastereomer of the dinucleoside monophosphate
was dissolved in 20% aqueous acetonitrile and was irradiated
at 5 C in a Pyrex immersion well apparatus ﬁtted with a
Figure 1. (A) Formation of the Dewar photoproduct. The dinucleoside
monophosphate of the (6–4) photoproduct (2) was irradiated with Pyrex-
filtered light from a 100 W high-pressure mercury lamp for 0 h (a), 1 h (b),
2 h (c) and 4 h (d), and the samples were analyzed by HPLC, using an
acetonitrile gradient from 0 to 5% for 16 min. (B) Absorption spectra of 2 (a)
and the irradiation product (b). The absorption spectra of the two peaks of
trace b in (A) were extracted with the data processing software for the
photodiode array detector.
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aliquots of the solution were analyzed by reversed-phase
HPLC, and the decrease of the starting material, as deter-
mined from the peak areas of the chromatograms at
325 nm, was monitored (Supplementary Figure 2). After
70 min, the (6–4) photoproduct was consumed almost com-
pletely and was converted to a single product, which did
not absorb UV light with wavelengths longer than 280 nm
(Figure 2A). The same results were obtained regardless of
the stereochemistry of the phosphotriester linkage. Aliquots
of the products were treated with aqueous ammonia at
room temperature for 2 h for deprotection and were subjected
to HPLC analysis. As shown in Figure 2B, the deprotected
products were identical to the authentic sample of the
Dewar photoproduct obtained by irradiation of the depro-
tected (6–4) photoproduct (trace d in Figure 1A).
The putative Dewar-containing dinucleoside monopho-
sphates (5a and 5b) were puriﬁed separately by reversed-
phase chromatography and were analyzed by
1H-NMR
spectroscopy. The proton signals were assigned using
COSY and ROESY spectra, and as reported for the Dewar
photoproduct without the protecting groups (3), ROESY
crosspeaks were observed between pT CH3 and Tp H30 and
between pT CH3 and pT H30 for both 5a and 5b. It was
also reported that the conversion of the (6–4) photoproduct
to its Dewar valence isomer resulted in an up-ﬁeld shift of
the H6 signal of the 30 base moiety (3). In the present
study, the chemical shifts of H6 were 7.84, 8.01, 4.94 and
4.96 for 4a, 4b, 5a and 5b, respectively. This observation,
together with the HPLC analysis shown in Figure 2B, the
UV absorption spectra and the molecular weight determined
by high-resolution mass spectrometry, demonstrated that the
obtained products were the dinucleoside monophosphates of
the Dewar photoproduct.
The dinucleoside monophosphates bearing the Dewar
photoproduct (5a and 5b) were converted to the 50-DMT deri-
vatives (6a and 6b) before the removal of the 30-protecting
group to yield 7a and 7b, in the same way as described for
Figure 2. (A) Conversion of 4a and 4b to 5a and 5b. Compounds 4a (a) and 4b (c) were irradiated with a 450 W high-pressure mercury lamp for 1 h, and the
starting materials (a and c) and the reaction mixtures (b and d) were analyzed by HPLC, using an acetonitrile gradient from 11 to 17% for 20 min. The thick and
thin lines show the chromatograms monitored at 325 and 245 nm, respectively. (B) Deprotection of 5a and 5b. Aliquots of 5a and 5b were treated with aqueous
ammonia at room temperature for 2 h, and were analyzed by HPLC after evaporation (a and b, respectively). (c) A mixture of the deprotected compounds was
co-injected with the authentic Dewar photoproduct (trace d in Figure 1A). The acetonitrile gradient was the same as that described in the legend to Figure 1A.
Figure 3. Reversed-phase HPLC analysis of crude oligonucleotides after deprotection. (A and B) The 20mer (A) and the 30mer (B) synthesized by the ordinary
method using tetrazole. (C) The 20mer synthesized by the BIT-activation method. The HPLC conditions are described in Materials and Methods.
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was 2.6-fold larger than that of 7a, 7b was used for the pre-
paration of the phosphoramidite building block. After the
phosphitylation of 7b, we tried to purify the phosphoramidite
building block of the Dewar photoproduct (8) by chromato-
graphy on silica gel using a solvent system of chloroform–
methanol containing 0.1% pyridine, as developed for the
(6–4) photoproduct. However, a
31P-NMR measurement
revealed that the phosphoramidite was degraded during this
chromatographic puriﬁcation. Both of the phosphoramidite
signals were diminished, and a new signal emerged at
11.66 p.p.m. The degradation was reproducible and also
occurred when 7a was used. This result suggested that the
phosphoramidite moiety attached to the dinucleoside mono-
phosphate of the Dewar photoproduct is more labile than
those in other building blocks. After testing several solvent
systems, we found that the phosphoramidite could be
obtained in an intact form by ﬂash chromatography using
chloroform containing 0.5% pyridine.
In this study, the two phosphorus diastereomers were sepa-
rated at the initial stage, in order to characterize the inter-
mediates by NMR spectroscopy, but it is possible to use a
mixture of the diastereomers as we are practicing in the
case of the (6–4) photoproduct.
Synthesis of oligonucleotides containing
the Dewar photoproduct
Using the phosphoramidite buildingblock ofthe Dewar photo-
product (8) prepared as above, a 12mer, d(CA-Dw-AGCAC-
GAC), a 20mer, d(CCTACGCAAAT-Dw-GGCATCC), and
a 30mer, d(CTCGTCAGCATC-Dw-CATCATACAGTCAG-
TG), in which Dw represents the Dewar valence isomer of
the (6–4) photoproductformed attheTT site,were synthesized
on a DNA synthesizer. Since this photoproduct is labile under





2-(4-isopropylphenoxy)acetylguanine, which can be depro-
tected under mild conditions, were used together with that of
unprotected thymine. After the chain assembly, the oligonu-
cleotides were cleaved from the support and deprotected by
the treatment with aqueous ammonia at room temperature
for 2 h. Analysis of the crude samples of the obtained oligonu-
cleotideswasperformed byreversed-phaseHPLC,asshownin
Figure 3A and B. A major peak was obtained in each case, but
many peaks of impurities were detected at longer retention
times. These impurities were also detected in our previous
studies on the (6–4) photoproduct, and they were assumed to
be formed by the coupling of the phosphoramidites with the
N3 imino function of the 50 component of the (6–4) photopro-
duct (25,26,33). Since the 50 component of the Dewar isomer
has the same chemical structure as that of the (6–4) photopro-
duct, this type of branching side reaction must have occurred.
To verify this proposal, as well as to improve the yields of
the desired oligonucleotides, the tetrazole was replaced with
benzimidazolium triﬂate (BIT), which was originally used as
an activator of phosphoramidites by Hayakawa’s group
(34,35) and prevented the by-product formation in the synth-
esis of (6–4) photoproduct-containing oligonucleotides (33).
As shown in Figure 3C, the results were improved to a great
extent using this alternative activator.
The oligonucleotides were puriﬁed by reversed-phase
HPLC and the 12mer was analyzed by MALDI-TOF mass
spectrometry (Supplementary Figure 3). The calculated and
obtained m/z values in the negative ion mode were 3611.74
and 3611.94, respectively. The presence of the Dewar photo-
product in the obtained oligonucleotides was demonstrated
using the 12mer. In our previous study (12), the same
Dewar photoproduct-containing 12mer was prepared by irra-
diation of the (6–4) photoproduct-containing one, and these
two oligonucleotides were separated from each other by
reversed-phase HPLC. This experiment was performed using
the 12mer synthesized in the present study. As shown in
Figure 4A, the 12mer in question coeluted with the Dewar
photoproduct-containing 12mer that was used in our previous
study (12), whereas it was separated from the (6–4)
photoproduct-containing 12mer. Further characterization of
the Dewar 12mer was performed using the UV conversion
to the (6–4) photoproduct and the enzymatic digestion, as
shown in Supplementary Figures 4 and 5, respectively. In
Figure 4. (A) Reversed-phase HPLC analysis of the Dewar 12mer.
(a) The 12mer synthesized in this study, (b) co-injection with the
Dewar photoproduct-containing 12mer prepared by irradiation of the (6–4)
photoproduct-containing 12mer and (c) co-injection with the (6–4)
photoproduct-containing 12mer with the same sequence context. The thick
and thin lines show the chromatograms monitored at 325 and 254 nm,
respectively, and the 325 nm chromatogram is magnified by a factor of 5. (B)
Analysis of the (6–4) photolyase reaction with the (6–4) 12mer (a) and the
Dewar 12mer (b and c). The reaction times were 3 h (a and b) and 24 h (c).
The HPLC conditions are described in Materials and Methods.
4412 Nucleic Acids Research, 2006, Vol. 34, No. 16the latter experiment, the phosphodiester linkage on the 30 side
of the photoproduct was not cleaved. However, no difference
was observed between the oligonucleotide synthesized in
this study and the authentic sample prepared by irradiation
of the (6–4) photoproduct-containing oligonucleotide, and
the presence of the Dewar photoproduct was demonstrated
by the UV conversion to the (6–4) photoproduct (trace d in
Supplementary Figure 5A). These results show that the
Dewar photoproduct-containing oligonucleotides, which are
free from contamination with the (6–4) photoproduct-
containing oligomers, can be synthesized using the method
described here.
Reaction and binding of (6–4) photolyase with Dewar
photoproduct-containing oligonucleotides
The (6–4) photolyase was ﬁrst discovered in a cell extract of
Drosophila melanogaster (20), and subsequently was found
in X.laevis (36) and Arabidopsis thaliana (37). This enzyme
contains ﬂavin adenine dinucleotide (FAD) as a chromophore
(36), and the analysis of its reaction strongly suggested
that this enzyme repairs the (6–4) photoproducts to their ori-
ginal pyrimidines by utilizing blue to near-UV light (20,38).
We demonstrated previously that this enzyme restored the
pyrimidines of the (6–4) photoproducts formed at the TT
(31) and TC (26) sites to their normal forms, and proposed
the repair mechanism of this enzyme (39). Although a crystal
structure of CPD photolyase, another enzyme for CPD repair,
has been solved in a complex form with its substrate DNA
(40), no structural information has been reported for the
(6–4) photolyase thus far. In the previous studies, the (6–4)
photolyase could bind DNA containing the Dewar photopro-
duct, but the repair rate was reduced to a great extent when
the Dewar photoproduct-containing DNA was used as a
substrate (21,31). Therefore, this type of lesion may be useful
in the co-crystallization experiments of the (6–4) photolyase.
To test the utility of the Dewar photoproduct-containing
DNA, we veriﬁed the (6–4) photolyase reaction using the
chemically synthesized oligonucleotides. The 12mer contain-
ing the Dewar photoproduct, as well as that containing
the (6–4) photoproduct in the same sequence context, was
treated with X.laevis (6–4) photolyase, and the reaction
mixtures were analyzed by reversed-phase HPLC. As
shown in Figure 4B, the (6–4) 12mer was converted to the
undamaged 12mer (TT 12mer) by exposing the reaction mix-
ture to ﬂuorescent lighting for 3 h (trace a), and the repair was
conﬁrmed by co-injection of the product with the TT 12mer.
In contrast, the peak of the TT 12mer was not detected in the
Dewar case (trace b) and prolonged exposure (up to 24 h) did
not cause any change (trace c). Since there was a possibility
that the above results were obtained by the loss of the afﬁnity
of the (6–4) photolyase for the Dewar photoproduct-
containing DNA, the enzyme binding was analyzed using a
ﬂuorescent base analog, 2-aminopurine. In the case of the
CPD photolyase, ﬂipping of the CPD lesion upon enzyme
binding was shown by using a complementary strand contain-
ing 2-aminopurine (41), and the same mechanism was pro-
posed for the (6–4) photolyase (39). Therefore, this type of
experiment was expected to demonstrate the two phenomena,
the enzyme binding and the base ﬂipping, simultaneously. The
Dewar photoproduct-containing 20mer was hybridized to
d(GGATGCC-Ap-AATTTGCGTAGG), in which Ap repre-
sents 2-aminopurine. In this duplex, the 2-aminopurine was
opposite the 30 component of the Dewar photoproduct. We
changed the position of 2-aminopurine in this sequence con-
text, and the ﬂuorescence intensity observed for the duplex
was sometimes close to that of the single-stranded oligonu-
cleotide containing this ﬂuorescent base analog (data not
Figure 5. (A and B) Fluorescence emission spectra of the Dewar (red), (6–4) (blue) and TT (green) 20mers hybridized to a complementary strand containing
2-aminopurine in the absence (A) and in the presence (B) of the (6–4) photolyase. (C and D) Fluorescence emission spectra of the (6–4) 20mer hybridized to a
complementary strand without 2-aminopurine in the absence (C) and in the presence (D) of the (6–4) photolyase.
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aminopurine has been reported recently for another lesion-
containing DNA (42). Using the above-mentioned duplex, as
well as the undamaged and (6–4) photoproduct-containing
duplexes as negative and positive controls, respectively, ﬂuor-
escence emission spectra were measured in the absence and
presence of the (6–4) photolyase (Figure 5A and B). Since
the (6–4) photoproduct is a ﬂuorescent base, emission spectra
of the (6–4) photoproduct-containing duplex without 2-
aminopurine were measured under the same conditions, to
conﬁrm that its ﬂuorescence did not affect this analysis
(Figure 5C and D). Moreover, there was a possibility that
ﬂuorescence resonance energy transfer might occur between
2-aminopurine and the (6–4) photoproduct, but we conﬁrmed
that such an effect was small enough for this experiment (data
not shown). An increase of the ﬂuorescence intensity upon the
addition of the enzyme was observed for the Dewar
photoproduct-containing duplex, but it was much smaller
than that observed for the (6–4) photoproduct-containing
duplex. These results indicate that the (6–4) photolyase
binds the DNA containing the Dewar photoproduct and
induces a structural change in DNA to some extent. However,
it is suggested that the binding mode is different between the
(6–4) photoproduct-containing substrate and the Dewar
isomer-containing duplex although the reported afﬁnities of
this enzyme for these two types of duplexes are similar (21,31).
We have synthesized a phosphoramidite building block
of the Dewar valence isomer of the (6–4) photoproduct
formed at the thymidylyl(30–50)thymidine site and success-
fully incorporated it into oligodeoxyribonucleotides. Using
these oligonucleotides, the reaction and the binding of the
(6–4) photolyase were analyzed, and the results suggested
an enzyme binding mode different from the recognition of
the original substrate. It is expected that oligonucleotides
synthesized by this method will contribute to molecular and
structural biology in the ﬁeld of mutagenesis and DNA repair.
SUPPLEMENTARY DATA
Supplementary data are available at NAR Online.
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